Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET) — Stella

Home/Metastatic Colorectal Cancer ctDNA Surveillance/Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)

View on ClinicalTrials.gov

Recruiting

Back to Metastatic Colorectal Cancer ctDNA Surveillance trials

Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)

Trial locations(1 site)

China

Fudan University Shanghai Cancer Center, Shanghai

Key details

Sponsor

Fudan University

Enrollment target

~497 participants

Started

October 2025

Primary completion

October 2028

Age range

18 Years – 75 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.